164 related articles for article (PubMed ID: 26415707)
21. Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
Guo D; Kassiri Z; Basu R; Chow FL; Kandalam V; Damilano F; Liang W; Izumo S; Hirsch E; Penninger JM; Backx PH; Oudit GY
Circ Res; 2010 Nov; 107(10):1275-89. PubMed ID: 20847309
[TBL] [Abstract][Full Text] [Related]
22. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
[TBL] [Abstract][Full Text] [Related]
23. Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium.
Toba H; de Castro Brás LE; Baicu CF; Zile MR; Lindsey ML; Bradshaw AD
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E1027-35. PubMed ID: 27143554
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium.
Kiczak L; Tomaszek A; Bania J; Paslawska U; Zacharski M; Janiszewski A; Rybinska I; Dziegiel P; von Haehling S; Ardehali H; Jankowska EA; Ponikowski P
J Physiol Pharmacol; 2014 Jun; 65(3):365-75. PubMed ID: 24930508
[TBL] [Abstract][Full Text] [Related]
25. Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution.
Iyer RP; de Castro Brás LE; Patterson NL; Bhowmick M; Flynn ER; Asher M; Cannon PL; Deleon-Pennell KY; Fields GB; Lindsey ML
J Mol Cell Cardiol; 2016 Nov; 100():109-117. PubMed ID: 27746126
[TBL] [Abstract][Full Text] [Related]
26. Targeted deletion of MMP-9 attenuates myocardial contractile dysfunction in heart failure.
Moshal KS; Rodriguez WE; Sen U; Tyagi SC
Physiol Res; 2008; 57(3):379-384. PubMed ID: 17552869
[TBL] [Abstract][Full Text] [Related]
27. [Myocardial matrix metalloproteinases activities in mice with viral myocarditis and their relationship with cardiac function and myocardial collagen amount].
Meng XH; Wang Y; Zhuang JX; Chen Y; Jin YP; Han XZ; Wang YL
Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):605-8. PubMed ID: 15347449
[TBL] [Abstract][Full Text] [Related]
28. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
[TBL] [Abstract][Full Text] [Related]
29. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
[TBL] [Abstract][Full Text] [Related]
30. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.
Spinale FG; Coker ML; Heung LJ; Bond BR; Gunasinghe HR; Etoh T; Goldberg AT; Zellner JL; Crumbley AJ
Circulation; 2000 Oct; 102(16):1944-9. PubMed ID: 11034943
[TBL] [Abstract][Full Text] [Related]
31. Novel role of extracellular matrix protein 1 (ECM1) in cardiac aging and myocardial infarction.
Hardy SA; Mabotuwana NS; Murtha LA; Coulter B; Sanchez-Bezanilla S; Al-Omary MS; Senanayake T; Loering S; Starkey M; Lee RJ; Rainer PP; Hansbro PM; Boyle AJ
PLoS One; 2019; 14(2):e0212230. PubMed ID: 30789914
[TBL] [Abstract][Full Text] [Related]
32. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
Yang YJ; Zhang X; Zhu WL; Huang Y
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1693-6. PubMed ID: 16854324
[TBL] [Abstract][Full Text] [Related]
33. Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure.
Moshal KS; Tyagi N; Moss V; Henderson B; Steed M; Ovechkin A; Aru GM; Tyagi SC
J Cell Mol Med; 2005; 9(3):704-13. PubMed ID: 16202218
[TBL] [Abstract][Full Text] [Related]
34. Age and SPARC change the extracellular matrix composition of the left ventricle.
de Castro Brás LE; Toba H; Baicu CF; Zile MR; Weintraub ST; Lindsey ML; Bradshaw AD
Biomed Res Int; 2014; 2014():810562. PubMed ID: 24783223
[TBL] [Abstract][Full Text] [Related]
35. Abnormal cardiac wall motion and early matrix metalloproteinase activity.
García RA; Brown KL; Pavelec RS; Go KV; Covell JW; Villarreal FJ
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1080-7. PubMed ID: 15486029
[TBL] [Abstract][Full Text] [Related]
36. Exercise training initiated in late middle age attenuates cardiac fibrosis and advanced glycation end-product accumulation in senescent rats.
Wright KJ; Thomas MM; Betik AC; Belke D; Hepple RT
Exp Gerontol; 2014 Feb; 50():9-18. PubMed ID: 24280067
[TBL] [Abstract][Full Text] [Related]
37. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.
Li YY; Feng YQ; Kadokami T; McTiernan CF; Draviam R; Watkins SC; Feldman AM
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12746-51. PubMed ID: 11070088
[TBL] [Abstract][Full Text] [Related]
38. Early activation of myocardial matrix metalloproteinases and degradation of cardiac troponin I after experimental subarachnoid hemorrhage.
Lin NN; Cheng CC; Lee YF; Fu YC; Chen JS; Ho SP; Chiu YT
J Surg Res; 2013 Jan; 179(1):e41-8. PubMed ID: 22475348
[TBL] [Abstract][Full Text] [Related]
39. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
[TBL] [Abstract][Full Text] [Related]
40. The impact of age on cardiac function and extracellular matrix component expression in adverse post-infarction remodeling in mice.
Nagel F; Santer D; Stojkovic S; Kaun C; Schaefer AK; Krššák M; Abraham D; Bencsik P; Ferdinandy P; Kenyeres E; Szabados T; Wojta J; Trescher K; Kiss A; Podesser BK
Exp Gerontol; 2019 May; 119():193-202. PubMed ID: 30763602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
